Reagents and Methods for Tetrazine Synthesis
Technology
Bioorthogonal chemistry, especially tetrazine bioorthogonal chemistry, has gained significant attention for its potential applications in living systems, particularly in the fields of imaging, detection, and diagnostics. The popularity of tetrazine bioorthogonal chemistry is due to its rapid and tunable kinetics, the availability of high-quality fluorogenic probes, and its selectivity in reactions. However, incorporating tetrazines into complex molecules is often impeded by the hazardous chemistry typically used in their synthesis and the use of large linking structures that can affect the effectiveness of the biologically active compound. This invention introduces a Silver-mediated Pd-catalyzed cross-coupling method using thioalkyltetrazine reagents, which has been tested for safety, to incorporate tetrazines. This novel approach replaces older reagents, eliminating the need for hydrazine and enhancing tetrazine functionality by eliminating a large linker group. It also prevents the formation of volatile high-nitrogen byproducts. This method enables the high-yield synthesis of various boronic acids for introducing tetrazines, improves access to important conjugates for cellular imaging, and facilitates the production of micro-fibrous materials for guiding cell contact. The elimination of the bulky linker group enhances the fluorogenic properties of fluorophores, their cellular wash-out capabilities, protein modification, and F-PET imaging.
Benefits
- This technology offers a safer method for incorporating tetrazines into complex molecules by eliminating the use of hazardous hydrazine, which is typically employed in tetrazine syntheses.
- The new approach eliminates the need for large linker groups between the active pharmaceutical ingredient and the ligand, thereby improving the physiochemical properties of the attached ligand.
- It leads to a significant increase in the yield of biologically relevant compounds, making it more effective for protein modification, cellular labeling, in vivo imaging, and targeted drug delivery.
- The novel reagent used in this technology also eliminates the generation of volatile tetrazine byproducts, contributing to cleaner and more efficient syntheses.
- This technology enhances scalability and widens its application scope, allowing for more efficient and versatile synthesis.
Applications
- Pharmaceutical companies
- Biotechnology companies
- Chemical manufacturing companies
- Diagnostic device manufacturers.